Ophthalmic antihistamines and decongestants

Definition
Ophthalmic antihistamines and decongestants are topical eye medications used to relieve allergic conjunctivitis and other forms of ocular allergy or irritation. These agents act locally on ocular tissues to reduce itching, redness, tearing, and swelling caused by the body's allergic or inflammatory response to allergens such as pollen, dust, pet dander, or mold. Some are also used in minor irritative conditions such as viral conjunctivitis, contact lens-related irritation, or exposure to wind and smoke.

This drug class includes H1 receptor antagonists, mast cell stabilizers, dual-acting agents, and vasoconstrictive decongestants (α-adrenergic agonists). These agents are typically formulated as eye drops and are available as prescription or over-the-counter (OTC) products depending on the molecule and indication.

---

1. Mechanism of Action

A. Antihistamines (H1 receptor antagonists)

• Block histamine H1 receptors in conjunctival and eyelid tissues, thereby reducing itching and hyperemia.

• Rapid onset but short duration unless combined with mast cell stabilizing action.

B. Mast Cell Stabilizers

• Inhibit degranulation of mast cells, thus preventing the release of histamine, prostaglandins, and leukotrienes involved in the allergic cascade.

• Slower onset but longer-term preventive effect.

C. Dual-Acting Agents

• Combine H1 receptor antagonism with mast cell stabilization for both rapid symptom relief and long-term control.

D. Decongestants (α-adrenergic agonists)

• Stimulate α1-adrenergic receptors in conjunctival blood vessels causing vasoconstriction.

• Reduce redness and hyperemia rapidly.

• Do not affect itching and may cause rebound redness (conjunctival hyperemia) with prolonged use.

---

2. Pharmacological Subclasses and Examples

A. Ophthalmic Antihistamines (H1 Blockers)

Generic Name	Brand Names	OTC/Prescription
Pheniramine	Naphcon-A, Opcon-A (combo)	OTC
Emedastine	Emadine	Rx
Antazoline	Vasocon-A (combo)	OTC

B. Mast Cell Stabilizers (Pure)

Generic Name	Brand Names	OTC/Prescription
Cromolyn sodium	Crolom	Rx
Nedocromil	Alocril	Rx
Lodoxamide	Alomide	Rx
Pemirolast	Alamast	Rx

C. Dual-Acting Agents (Antihistamine + Mast Cell Stabilizer)

Generic Name	Brand Names	OTC/Prescription
Olopatadine	Pataday, Patanol, Pazeo	OTC/Rx
Ketotifen fumarate	Zaditor, Alaway	OTC
Epinastine	Elestat	Rx
Azelastine	Optivar	Rx
Bepotastine	Bepreve	Rx
Alcaftadine	Lastacaft	Rx

D. Decongestants (α1-adrenergic agonists)

Generic Name	Brand Names	OTC/Prescription
Naphazoline	Clear Eyes, Naphcon, Visine	OTC
Tetrahydrozoline	Visine Original	OTC
Oxymetazoline	Visine L.R.	OTC
Phenylephrine	Relief Drops, Mydfrin	OTC
Brimonidine tartrate (low-dose)	Lumify (OTC)	OTC

Note: Lumify (brimonidine 0.025%) is unique among decongestants because it selectively targets α2 receptors, minimizing rebound hyperemia while still reducing redness.

---

3. Clinical Indications

Condition	Recommended Agents
Seasonal allergic conjunctivitis	Dual-acting agents, antihistamines, mast cell stabilizers
Vernal keratoconjunctivitis (VKC)	Mast cell stabilizers (e.g., cromolyn, lodoxamide)
Contact lens-related irritation	Ketotifen (if no preservatives), artificial tears
Non-specific ocular redness	Decongestants (short-term use)
Dry eye with allergic overlay	Lissamine green diagnostic, then dual-acting or mast cell agents

4. Dosing and Onset

Drug Type	Dosing Frequency	Onset of Action	Duration
Antihistamines	1–2 times daily	Minutes	4–12 hours
Mast Cell Stabilizers	2–4 times daily	Days to weeks	Long-term control
Dual-Acting Agents	1–2 times daily	Minutes	12–24 hours
Decongestants	Up to 4 times daily	Minutes	Up to 6 hours

5. Adverse Effects

Agent Type	Common Adverse Reactions
Antihistamines	Stinging, headache, dry eye, mild burning
Mast Cell Stabilizers	Transient burning, stinging, blurred vision
Dual-Acting Agents	Headache, eye irritation, taste changes (esp. azelastine)
Decongestants	Rebound redness (if prolonged), mydriasis, burning, dryness
Brimonidine (Lumify)	Dry eye, allergic conjunctivitis (rare), less rebound risk

6. Precautions and Contraindications

• Decongestants:

  • Avoid prolonged use >72 hours (except Lumify)

  • Contraindicated in narrow-angle glaucoma due to pupil dilation risk

  • May cause tachyphylaxis and rebound congestion

• Children and Infants:

  • Avoid use of brimonidine Rx strength (can cause CNS depression)

  • Use only low-dose Lumify (0.025%) if decongestant is required

• Contact Lens Wearers:

  • Remove lenses prior to instillation

  • Wait ≥15 minutes before reinsertion (especially if preserved with BAK)

• Pregnancy/Lactation:

  • Most agents are category C

  • Avoid decongestants unless essential

---

7. Formulations and Packaging

• Multidose Bottles: Contain preservatives like benzalkonium chloride (BAK)

• Preservative-Free Options:

  • Pataday once daily

  • Zaditor preservative-free variants

• Single-Use Vials: Ketotifen, olopatadine (limited brands)

• Low-Preservative: Preferred for chronic allergic conjunctivitis

---

8. Brand Name Comparisons (Global Availability)

Generic	US Brands	UK Brands	Other Intl Brands
Ketotifen	Zaditor, Alaway	Zaditen	Zabak, Zyrtec Itchy Eye
Olopatadine	Pataday, Pazeo	Opatanol	Patanol, Patanol S
Azelastine	Optivar	Allergodil	Histazolin, Azep
Emedastine	Emadine	Emadine	Emadine
Naphazoline + Pheniramine	Naphcon-A, Opcon-A	Optrex Allergy Eye Drops	Vasoclear, Visine-A

9. Combination Formulations

Combination	Brand	Use
Naphazoline + Pheniramine	Naphcon-A, Opcon-A	OTC for red, itchy eyes
Ketotifen + Decongestant (older)	No longer common	Replaced by dual-acting
Lodoxamide + Antihistamine	Alomide (monotherapy available)	VKC and chronic allergy

10. Comparison: OTC vs. Prescription Products

Category	Examples	Notes
OTC Only	Ketotifen (Zaditor, Alaway), Lumify	Rapid relief, suitable for mild allergies
Rx Only	Bepotastine, Azelastine, Epinastine	For moderate-to-severe allergic conjunctivitis
Rx and OTC	Olopatadine (Pataday OTC, Patanol Rx)	Dose and concentration differ by brand

11. Patient Counseling Points

• Do not use decongestants more than 3 consecutive days unless advised

• Refrigerate drops for soothing effect, unless otherwise stated

• Avoid touching dropper tip to eye or skin

• Shake suspensions before use (e.g., some formulations of olopatadine)

• Seek medical attention if vision changes, pain, or discharge occur

• Use drops before other ophthalmic ointments (wait 5–10 minutes)